1407709888; A Multicenter Randomized Placebo-controlled Double-blind 16 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinsons's Disease Subjects with Levodopa-Induced Dyskinesias
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to see if it is safe and still helpful to take a tablet that releases the amantadine hydrochloride into the body more slowly and is taken once a day.
Description
This is a randomized, double-blind, placebo controlled parallel group, 3-arm, Phase 3, multicenter study. This is a fixed dose trial (after a titration period) that will compare the efficacy and safety of Amantadine HCl Extended Release Tablets with placebo in subjects aged 30 to 85 with Parkinson?s disease who have Levodopa-Induced Dyskinesias.
Details
| Condition | Parkinson's Disease |
|---|---|
| Age | 30years - 85years |
| Clinical Study Identifier | TX4276 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.